Table 1

Summary and comparison of authorship characteristics for the five HSV-2 research priority areas

EpidemiologyDiagnosticsControl measuresInteraction with HIVMathematical modellingAll studies
Number of included articles (duplicates removed)9463447917297
Number of different LMICs from which studies were carried out37231321849
Percentage of studies with ≥1 author from LMIC (%)897666943582
Percentage of studies where first or last author is from LMIC (%)755241531856
Percentage of studies where first author is from LMIC (%)674832411849
Percentage of studies where last author is from LMIC (%)594227361941
Percentage of studies where first and last authors are from LMIC (%)523718231935
Percentage of studies where funding source is acknowledged (%)868680868985
Percentage of studies with LMIC funding source (of those that were funded) (%)45336161327
Crude relative risk of LMIC first or last author when funding is from LMIC compared with HIC2.36 (95% CI 1.93 to 2.89)
Gender of first authors (%)Male: 43
Female: 47
Male: 43
Female: 48
Male: 43
Female: 55
Male: 52
Female: 44
Male: 47
Female: 53
Male: 48
Female: 46
Gender last authors (%)Male: 61
Female: 29
Male: 54
Female: 35
Male: 55
Female: 43
Male: 56
Female: 39
Male: 65
Female: 29
Male: 58
Female: 36
Gender of first authors among studies where first author is from LMIC (%)Male: 46
Female: 43
Male: 43
Female: 43
Male: 43
Female: 50
Male: 59
Female: 31
Male: 67
Female: 33
Male: 50
Female: 41
Gender of first authors among studies where first author is from HIC (%)Male: 37
Female: 57
Male: 42
Female: 52
Male: 43
Female: 57
Male: 47
Female: 53
Male: 43
Female: 57
Male: 43
Female: 55
Gender of last authors among studies where first author is from LMIC (%)Male: 65
Female: 19
Male: 38
Female: 42
Male: 58
Female: 33
Male: 54
Female: 39
Male: 67
Female: 33
Male: 59
Female: 35
Gender of last authors among studies where first author is from HIC (%)Male: 56
Female: 44
Male: 67
Female: 31
Male: 53
Female: 47
Male: 58
Female: 40
Male: 69
Female: 31
Male:.58
Female: 41
  • The crude relative risk of LMIC first or last author when funding is from an LMIC compared with an HIC does not include studies with joint first/last authors.

  • HIC, high-income country; HSV-2, herpes simplex virus type-2; LMIC, low-income and middle-income country.